A regulatory role for CHD2 in myelopoiesis. Issue 6 (2nd July 2020)

• Record Type: Journal Article
• Authors: Shahin Varnoosfaderani, Farzaneh; Palau, Anna; Dong, Wenbo; Persson, Jenna; Durand-Dubief, Mickaël; Svensson, J Peter; Lennartsson, Andreas
• Is Part Of: Epigenetics. Volume 15:Issue 6/7(2020)
• Page Start: 702
• Page End: 714
• Publication Date: 2020-07-02
• Subjects: CHD2 -- myelopoiesis -- CRISPR-Cas9 library -- epigenetics; Epigenesis -- Periodicals; Epigenetica; 572.86505
• DOI: 10.1080/15592294.2019.1710913
• Languages: English
• ISSNs: 1559-2294

Abstract

ABSTRACT: The transcriptional program that dictates haematopoietic cell fate and differentiation requires an epigenetic regulatory and memory function, provided by a network of epigenetic factors that regulate DNA methylation, post-translational histone modifications and chromatin structure. Disturbed epigenetic regulation causes perturbations in the blood cell differentiation program that results in various types of haematopoietic disorders. Thus, accurate epigenetic regulation is essential for functional haematopoiesis. In this study, we used a CRISPR-Cas9 screening approach to identify new epigenetic regulators in myeloid differentiation. We designed a Chromatin-UMI CRISPR guide library targeting 1092 epigenetic regulators. Phorbol 12-myristate 13-acetate (PMA) treatment of the chronic myeloid leukaemia cell line K-562 was used as a megakaryocytic myeloid differentiation model. Both previously described developmental epigenetic regulators and novel factors were identified in our screen. In this study, we validated and characterized a role for the chromatin remodeller CHD2 in myeloid proliferation and megakaryocytic differentiation.